If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
158.60    1.40 (0.89%)
Bid:
158.40
Ask:
158.80
Spread: 0.40 (0.253%)
Market Cap: £905.26m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Holding(s) in Company

6 Aug 2015 13:52

ELEMENTIS PLC - Holding(s) in Company

ELEMENTIS PLC - Holding(s) in Company

PR Newswire

London, August 6

TR–1: Notifications of Major Interests in Shares

1: Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:Elementis PLC

2: Reason for notification (yes/no)
An acquisition or disposal of voting rightsyes
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attachedno
An acquisition or disposal of instruments with similar economic effect to qualifying financial instrumentsno
An event changing the breakdown of voting rightsno
Other (please specify):no

3. Full name of person(s) subject to the notification obligation:Standard Life Investments (Holdings) Limited (Parent Company) -5.06% comprised of: Standard Life Investments Limited - 5.06% Ignis Investment Services Limited - 0%
4. Full name of shareholder(s) (if different from 3.): Vidacos Nominees\HSBC
5. Date of the transaction (and date on which the threshold is crossed or reached):04/08/2015
6. Date on which issuer notified:05/08/2015
7. Threshold(s) that is/are crossed or reached:5%

8: Notified Details
A: Voting rights attached to shares
Class/type of share  If possible use ISIN codeGB0002418548
Situation previous to the triggering transaction
Number of sharesNumber of voting rights
23,063,78123,063,781
Resulting situation after the triggering transaction
Number of sharesNumber of voting rightsPercentage of voting rights
DirectIndirectDirectIndirect
23,378,78119,913,0593,465,7224.310.75

B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrumentExpiration dateExercise/ conversion period/dateNo. of voting rights that may be acquired (if the instrument exercised/converted)Percentage of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrumentExercise priceExpiration dateExercise/ Conversion periodNumber of voting rights instrument refers to% of voting rights
NominalDelta

Total (A+B+C)
Number of voting rightsPercentage of voting rights
23,378,7815.06

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
Standard Life Investments (Holdings) Limited (Parent Company) -5.06% comprised of: Standard Life Investments Limited - 5.06% Ignis Investment Services Limited - 0%

Proxy Voting:
10. Name of the proxy holder:N/A
11. Number of voting rights proxy holder will cease to hold:N/A
12. Date on which proxy holder will cease to hold voting rights:N/A

13. Additional information: N/A
14. Contact name:GIOS@standardlife.com Standard Life Investments Ltd
15. Contact telephone number:(0131) 245 6565

This notification is made in accordance with Rule 5.8.12 R(1) of the Disclosure and Transparency Rules sourcebook.

Wai WongCompany Secretary020 7408 93006 August 2015

Date   Source Headline
6th Jul 20265:24 pmRNSTransaction in Own Shares
1st Jul 20266:26 pmRNSTotal Voting Rights
29th Jun 20266:11 pmRNSTransaction in Own Shares
22nd Jun 20262:42 pmRNSTransaction in Own Shares
22nd Jun 20262:30 pmRNSTransaction in Own Shares
15th Jun 202612:42 pmRNSTransaction in Own Shares
8th Jun 20265:14 pmRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSCommencement of share buyback programme
2nd Jun 20267:00 amRNSSale of Pharma business & intended buyback launch
1st Jun 20269:58 amRNSTotal Voting Rights
5th May 20265:26 pmRNSHolding(s) in Company
1st May 20269:59 amRNSTotal Voting Rights
29th Apr 20263:47 pmRNSResult of AGM
29th Apr 20267:00 amRNSFirst quarter trading update
8th Apr 20264:14 pmRNSDirector/PDMR Shareholding
7th Apr 20263:06 pmRNSDirector/PDMR Shareholding
1st Apr 202610:18 amRNSTotal Voting Rights
30th Mar 20265:06 pmRNSCorrection - Admission to Trading
30th Mar 20261:58 pmRNSAdmission to Trading
26th Mar 202612:09 pmRNSNotice of AGM and Annual Report & Accounts
19th Mar 20267:00 amRNSDirectorate change
11th Mar 20263:18 pmRNSDirector/PDMR Shareholding
11th Mar 20263:18 pmRNSDirector/PDMR Shareholding
10th Mar 20263:40 pmRNSDirector/PDMR Shareholding
10th Mar 20263:40 pmRNSDirector/PDMR Shareholding
10th Mar 20263:39 pmRNSDirector/PDMR Shareholding
9th Mar 20265:14 pmRNSHolding(s) in Company
5th Mar 20265:11 pmRNSBlocklisting Interim Review
5th Mar 20264:57 pmRNSPreliminary Results - Correction
5th Mar 20267:00 amRNSPreliminary Results
2nd Mar 202610:00 amRNSTotal Voting Rights
25th Feb 20264:22 pmRNSDirectorate change
2nd Feb 202610:05 amRNSTotal Voting Rights
21st Jan 20267:00 amRNSTrading Update
2nd Jan 202611:10 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSConfirmation of Board changes
2nd Jan 20267:00 amRNSConfirmation of Board changes
24th Dec 202510:25 amRNSDirector/PDMR Shareholding
24th Dec 202510:25 amRNSDirector/PDMR Shareholding
15th Dec 20257:00 amRNSCompletion of Buyback programme
15th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20255:35 pmRNSTransaction in Own Shares
10th Dec 20256:12 pmRNSTransaction in Own Shares
9th Dec 20255:55 pmRNSTransaction in Own Shares
8th Dec 20255:52 pmRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20256:06 pmRNSTransaction in Own Shares
3rd Dec 20255:28 pmRNSTransaction in Own Shares
3rd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20255:49 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.